Overall rank by patents
#1,102
Across all tracked assignees
USPTO PatentsView assignee record - 387 granted patents across 25 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Auris holds 387 US patents across 25 technology areas, rank #1,102 of 50,000 tracked assignees.
Auris Health, Inc. has been granted 387 US utility patents between 2018 and 2025, placing Auris Health, Inc. at rank #1,102 across all assignees tracked by PlainPatent. This portfolio spans 25 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Auris Health, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Auris sits between Schneider Electric IT Corporation (389 patents, rank #1,098) and JNC Corporation (385 patents, rank #1,106) - the closest US assignees by grant volume. The composite Innovation Score of 59.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 338 grants, compared with 49 in the 2015–2019 window, a +590% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Auris Health, Inc.'s 19.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 25 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Auris Health, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SCHNEIDER ELECTRIC IT CORPORATION
389 patents
View, Inc.
389 patents
Japan Science and Technology Agency
388 patents
Valeo Systemes Thermiques
388 patents
CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED
387 patents
Auris Health, Inc.
387 patents
Infinera Corp.
386 patents
PPC BROADBAND, INC.
386 patents
JNC CORPORATION
385 patents
What this shows Auris holds 387 patents at rank #1,102, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,102 in granted patent volume.
Other assignees with the most granted patents in Auris's primary technology class.
Auris's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
60 Top 4% higher than 96% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 16 | 4.1% |
| 2019 | 33 | 8.5% |
| 2020 | 53 | 13.7% |
| 2021 | 42 | 10.9% |
| 2022 | 50 | 12.9% |
| 2023 | 60 | 15.5% |
| 2024 | 72 | 18.6% |
| 2025 | 61 | 15.8% |
Top 15 of 25 technology areas
Overall rank by patents
#1,102
Across all tracked assignees
59.7 out of 100
How to use this portfolio
Auris's 387 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.